Key result
~71% of elderly psychiatry outpatients receive interacting QT-prolonging medications capable of causing TdP.
Why the study?
Psychotropic medications prolong the QTc interval, which in elderly patients is linked to increased risks of all-cause and coronary heart disease mortality.
Cross-Sectional (n=208)
No
A high prevalence (70.7%) of elderly psychiatric outpatients are exposed to QT-prolonging drug-drug interactions, highlighting the critical need for careful medication review and ECG monitoring in this vulnerable population.
Answers are grounded in this paper and cite their sources.
Prevalent QT-prolonging combinations in elderly psychiatric outpatients warrant vigilance; leaves open whether monitoring reduces TdP risk.
INTRODUCTION AND OBJECTIVES: Psychotropic medications extend the corrected QT (QTc) period in the ECG. Psychiatric patients exposed to ≥ 1 psychotropic medication (s) represent a group with a marked probability of drug-activated QTc-prolongation. Prolonged QTc interval in elderly patients (age > 60 years) is connected to a greater risk of all-cause and coronary heart disease deaths. We investigated the pattern of utilization of QTc-interval prolonging medications, QT-extending interactions between drugs, and prevalence of QTc-interval prolonging risk factors in elderly patients. METHODS: This was a cross-sectional, prospective study at the Psychiatry OPD at All India Institute of Medical Sciences (AIIMS), Rishikesh, Uttarakhand, India from October 1, 2017 to December 31, 2018 employing the pertinent prescriptions. RESULTS: receptor antagonist (15) therapeutic categories. CONCLUSIONS: Many geriatric patients were administered drugs and drug combinations with heightened proclivity towards QT-interval prolongation. Therefore, we need to exigently embrace precautionary safety interventions, to be vigilant, and forestall QT-prolongation and TdP in clinical settings. Online evidence-based drug information resources can aid clinicians in choosing drugs for psychiatric patients.
No takes yet. Share an insight, caveat, or question.
Das et al. (2020) conducted a cross-sectional in Psychiatric disorders (n=208). QTc-interval prolonging medications was evaluated on Prevalence of using interacting agents with the capacity to produce Torsade de Pointes (TdP). Among 208 elderly psychiatry outpatients, 70.7% were prescribed interacting medications with the capacity to produce Torsade de Pointes, highlighting a high prevalence of QT-prolonging drug combinations.
Synapse has enriched 10 related papers. Consider them for comparative context: